<DOC>
	<DOCNO>NCT00900796</DOCNO>
	<brief_summary>The objective observational study determine incidence response patient predictive factor major clinical response active ankylosing spondylitis ( AS ) patient start anti-tumor necrosis factor ( anti-TNF ) therapy correlate finding patient switch one another anti-TNF due inefficacy usual clinical practice condition Spain .</brief_summary>
	<brief_title>Study Evaluating Predictors Response Patients With Ankylosing Spondylitis</brief_title>
	<detailed_description>A sample size 240 patient , 120 expose 120 exposed factor response . Sample obtain consecutive patient attend rheumatology setting include study fulfill inclusion criterion</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<criteria>Patients diagnose active AS start antiTNF therapy follow standard clinical practice per summary product characteristic dos . &gt; 18 year , gender , disease duration Signature inform consent Previous treatment biological therapy Active tuberculosis infection ( local guideline appropriate screen treatment tuberculosis set antiTNF therapy must follow )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Ankylosing spondylitis ; predictive factor</keyword>
</DOC>